These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 32436348)
1. A PIK3CA transgenic mouse model with chemical carcinogen exposure mimics human oral tongue tumorigenesis. Tan MT; Wu JG; Callejas-Valera JL; Schwarz RA; Gillenwater AM; Richards-Kortum RR; Vigneswaran N Int J Exp Pathol; 2020 Feb; 101(1-2):45-54. PubMed ID: 32436348 [TBL] [Abstract][Full Text] [Related]
2. 4NQO carcinogenesis: a mouse model of oral cavity squamous cell carcinoma. Hawkins BL; Heniford BW; Ackermann DM; Leonberger M; Martinez SA; Hendler FJ Head Neck; 1994; 16(5):424-32. PubMed ID: 7960739 [TBL] [Abstract][Full Text] [Related]
3. García-Carracedo D; Cai Y; Qiu W; Saeki K; Friedman RA; Lee A; Li Y; Goldberg EM; Stratikopoulos EE; Parsons R; Lu C; Efstratiadis A; Philipone EM; Yoon AJ; Su GH Mol Cancer Res; 2020 Jun; 18(6):822-834. PubMed ID: 32152233 [TBL] [Abstract][Full Text] [Related]
4. Local Anti-PD-1 Delivery Prevents Progression of Premalignant Lesions in a 4NQO-Oral Carcinogenesis Mouse Model. Shi Y; Xie TX; Leach DG; Wang B; Young S; Osman AA; Sikora AG; Ren X; Hartgerink JD; Myers JN; Rangel R Cancer Prev Res (Phila); 2021 Aug; 14(8):767-778. PubMed ID: 34021022 [TBL] [Abstract][Full Text] [Related]
5. 4NQO induced carcinogenesis: A mouse model for oral squamous cell carcinoma. Sagheer SH; Whitaker-Menezes D; Han JYS; Curry JM; Martinez-Outschoorn U; Philp NJ Methods Cell Biol; 2021; 163():93-111. PubMed ID: 33785171 [TBL] [Abstract][Full Text] [Related]
6. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis. Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610 [TBL] [Abstract][Full Text] [Related]
7. Enhancement of tongue carcinogenesis in Hras128 transgenic rats treated with 4-nitroquinoline 1-oxide. Naoi K; Sunagawa N; Yoshida I; Morioka T; Nakashima M; Ishihara M; Fukamachi K; Itoh Y; Tsuda H; Yoshimi N; Suzui M Oncol Rep; 2010 Feb; 23(2):337-44. PubMed ID: 20043093 [TBL] [Abstract][Full Text] [Related]
8. [A rat model of tongue mucosa squamous cell carcinoma induced by oral administration of 4NQO in drinking water]. Liu X; He R; Chen W Zhonghua Kou Qiang Yi Xue Za Zhi; 1999 Nov; 34(6):354-6. PubMed ID: 11776878 [TBL] [Abstract][Full Text] [Related]
9. Homeobox C5 expression is associated with the progression of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Moon SM; Ahn MY; Kwon SM; Kim SA; Ahn SG; Yoon JH J Oral Pathol Med; 2012 Jul; 41(6):470-6. PubMed ID: 22385119 [TBL] [Abstract][Full Text] [Related]
10. Specific Deletion of p16 Ishida K; Tomita H; Kanayama T; Noguchi K; Niwa A; Kawaguchi M; Miyai M; Matsuo M; Imaizumi Y; Kato K; Hatano Y; Hirata A; Okada H; Shibata T; Hara A Am J Pathol; 2020 Jun; 190(6):1332-1342. PubMed ID: 32194051 [TBL] [Abstract][Full Text] [Related]
11. Grape seed extract and resveratrol prevent 4-nitroquinoline 1-oxide induced oral tumorigenesis in mice by modulating AMPK activation and associated biological responses. Shrotriya S; Tyagi A; Deep G; Orlicky DJ; Wisell J; Wang XJ; Sclafani RA; Agarwal R; Agarwal C Mol Carcinog; 2015 Apr; 54(4):291-300. PubMed ID: 24243690 [TBL] [Abstract][Full Text] [Related]
13. An animal model for the rapid induction of tongue neoplasms in human c-Ha-ras proto-oncogene transgenic rats by 4-nitroquinoline 1-oxide: its potential use for preclinical chemoprevention studies. Suzuki R; Kohno H; Suzui M; Yoshimi N; Tsuda H; Wakabayashi K; Tanaka T Carcinogenesis; 2006 Mar; 27(3):619-30. PubMed ID: 16219633 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity. Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705 [TBL] [Abstract][Full Text] [Related]
15. Genomic instability in non-neoplastic oral mucosa cells can predict risk during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Ribeiro DA; Fávero Salvadori DM; da Silva RN; Ribeiro Darros B; Alencar Marques ME Oral Oncol; 2004 Oct; 40(9):910-5. PubMed ID: 15380169 [TBL] [Abstract][Full Text] [Related]
16. No mutations found in exon 2 of gene p16CDKN2A during rat tongue carcinogenesis induced by 4-nitroquinoline-1-oxide. Minicucci EM; da Silva GN; Ribeiro DA; Favero Salvadori DM J Mol Histol; 2009 Feb; 40(1):71-6. PubMed ID: 19255859 [TBL] [Abstract][Full Text] [Related]
17. Use of carcinogen-induced premalignant oral lesions in a dendritic cell-based vaccine to stimulate immune reactivity against both premalignant oral lesions and oral cancer. Young MR J Immunother; 2008; 31(2):148-56. PubMed ID: 18481384 [TBL] [Abstract][Full Text] [Related]
18. An Immunocompetent Mouse Model of HPV16(+) Head and Neck Squamous Cell Carcinoma. Carper MB; Troutman S; Wagner BL; Byrd KM; Selitsky SR; Parag-Sharma K; Henry EC; Li W; Parker JS; Montgomery SA; Cleveland JL; Williams SE; Kissil JL; Hayes DN; Amelio AL Cell Rep; 2019 Nov; 29(6):1660-1674.e7. PubMed ID: 31693903 [TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of bcl-2 and bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4-nitroquinoline 1-oxide. Ribeiro DA; Salvadori DM; Marques ME Int J Exp Pathol; 2005 Dec; 86(6):375-81. PubMed ID: 16309543 [TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of 4NQO-Induced Mouse Tongue Carcinogenesis by AKT Inhibitor through the MMP-9/RhoC Signaling Pathway and Autophagy. Yin P; Chen J; Wu Y; Gao F; Wen J; Zhang W; Su Y; Zhang X Anal Cell Pathol (Amst); 2022; 2022():3770715. PubMed ID: 36247874 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]